From FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data:

Diseased liver

Diseased liver—

Image: iStock/Rasi Bhadramani
https://www.istockphoto.com/portfolio/rasibhadramani?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

From Our Editors · Podcast
Xcelerating Life Sciences San Francisco: The Highlights Podcast
The AI, Big Data, and R&D Boom

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Xconomy on Demand

We offer a number of ways to subscribe for free!